eClinical technology company, Axiom Real-Time Metrics, will be recapitalized by Great Point Partners to provide eClinical solutions to increase service offerings for Phase I-III clinical trials.
AMRI has been acquired by a private equity firm and has already begun its search for “the next couple of acquisitions,” says its CEO – and the shopping list is long.
inVentiv Health announced last week that it has closed its previously announced transaction agreement with the private equity firm, Advent International.
Premier Research has become the most recent contract research organization (CRO) to receive funding from private equity as the industry looks for "like-minded" partners for the long run.
Trilantic Capital Partners Europe has bought a majority stake in Doppel Farmaceutici, citing the growth potential of Europe’s contracting market as the driver.
CRO consolidation has left market opportunities for providers who serve mid-size pharma, UK-based private equity firm Cinven says as it acquires Medpace.
Mitsubishi Chemical Holdings (MCHC) has announced plans to buy the ‘dominant’ pharma-grade HPMC capsule maker Qualicaps as the global gelatin shortage continues.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at inVentiv, Icon, ICTS, OSO and Warnex.
Private equity firm JLL Patheon Holdings went ahead yesterday with its unsolicited $2-per-share bid for Patheon that would take the company into private ownership.
One Equity Partners (OEP), the private equity arm of JPMorgan
Chase, is in the process of selling its stake in Quintiles for a
reported sum of over $3bn.
Japanese pharmaceutical company Shionogi has said it plans to sell
its capsule subsidiary Shionogi Qualicaps to private investment
group the Carlyle Group in order to focus on its drug development
activities.
